Roivant Sciences Ltd (ROIV)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 8.02B
P/E Ratio
0.00
Revenue (TTM)
$ 23.23M
Volume
0
52W High
$ 13.05
52W Low
$ 8.73
Dividend Yield
0.00%
Beta
1.15
Technicals
50-Day MA
11.3726
200-Day MA
11.1644
52 Week High
13.055
52 Week Low
8.73
About ROIV
Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.
Employees
750
Headquarters
London, United Kingdom
CEO
Mr. Matthew Gline
Latest News
Roivant Sciences Ltd. (ROIV) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
4 days ago • Google News
Leerink Partners Keeps Their Buy Rating on Roivant Sciences (ROIV) - The Globe and Mail
2 days ago • Google News